新型麻醉药物瑞马唑仑的临床应用进展

陈 琦1, 刘红 梅2, 王宝 忠1, 崔 博1
1.华北理工大学； 2.唐山市工人医院

摘要

摘要：瑞马唑仑是一种新型的超短效苯二氮䓬类药物，作用于γ-氨基丁酸A型受体产生类似咪达唑仑的镇静效果。其具有起效快、镇静效果确切、对呼吸循环抑制轻、不依赖肝肾代谢且代谢产物无活性、无蓄积作用、可被氟马西尼拮抗等特点，是一种应用前景广泛的新型镇静药物。本文从瑞马唑仑的药理学特点、临床应用和安全性方面进行综述，为其进步广泛应用提供参考。

关键词

关键词：瑞马唑仑；苯二氮䓬类；镇静药；麻醉ICU；镇静

参考

[1]中国成人 ICU 镇痛和镇静治疗指南[J].中华重症医学电子杂志(网络版),2018,4(02):90-113.[2]王春艳,于泳浩.瑞马唑仑临床研究进展[J].中华麻醉学杂志,2019,39(3):261-263.[3]Rogers W K, McDowell T S. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia inday-case surgical and non-surgical procedures[J]. IDrugs: theinvestigational drugs journal, 2010, 13(12): 929-937.[4]李彦峰,王钝.瑞马唑仑[J].中国药物化学杂志,2021,31(07):572.[5]Antonik L J, Goldwater D R, Kilpatrick G J, et al. A placebo-andmidazolam-controlled phase I single ascending-dose study evaluatingthe safety, pharmacokinetics, and pharmacodynamics of remimazolam(CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics[J].Anesthesia & Analgesia, 2012, 115(2): 274-283.[6]Wiltshire H R, Kilpatrick G J, Tilbrook G S, et al. A placebo-andmidazolam-controlled phase I single ascending-dose study evaluatingthe safety, pharmacokinetics, and pharmacodynamics of remimazolam(CNS 7056): Part II. Population pharmacokinetic and pharmacodynamicmodeling and simulation[J]. Anesthesia & Analgesia, 2012, 115(2):284-296.[7]Schüttler J, Eisenried A, Lerch M, et al. Pharmacokinetics andpharmacodynamics of remimazolam (CNS 7056) after continuous infusionin healthy male volunteers: part I. Pharmacokinetics and clinicalpharmacodynamics[J]. Anesthesiology, 2020, 132(4): 636-651.[8]余婉秋,李禹琼,朱圣姬等.苯磺酸瑞马唑仑与丙泊酚用于无痛结肠镜检查的有效性及安全性的随机、单盲、平行对照研究[J].贵州医药,2020,44(06):846-849+1009.[9]杨婉,孔令锁,陈兰仁.甲苯磺酸瑞马唑仑在老年患者无痛胃肠镜检查的应用[J].实用医学杂志,2021,37(20):2665-2669.[10]李长坤.甲苯磺酸瑞马唑仑在无痛宫腔镜检查中的麻醉效果及安全性分析[J].中国药物滥用防治杂志,2022,28(04):458-462.[11]Doi M, Morita K, Takeda J, et al. Efficacy and safety ofremimazolam versus propofol for general anesthesia: a multicenter,single-blind, randomized, parallel-group, phase IIb/III trial[J]. Journal ofAnesthesia, 2020, 34: 543-553.[12]Doi M, Hirata N, Suzuki T, et al. Safety and efficacy ofremimazolam in induction and maintenance of general anesthesia inhigh-risk surgical patients (ASA Class III): results of a multicenter,randomized, double-blind, parallel-group comparative trial[J]. Journal ofAnesthesia, 2020, 34: 491-501.[13]赵晓咏,夏瑞,刘香玉,刘伟伟,唐丽,徐伟,李启飞.瑞马唑仑用于 腹 部 手 术 患 者 全 麻 诱 导 与 维 持 的 效 果 [J]. 中 华 麻 醉 学 杂志,2021,41(7):823-826.[14]梁智.丙泊酚与咪达唑仑在重症肺炎患者有创机械通气中的镇静效果比较[J].临床合理用药杂志,2021,14(10):22-24.[15]王妮,龚勋,谭柏栋等.右美托咪定、咪达唑仑和丙泊酚在 ICU机械通气患者镇静治疗中的有效性和安全性：基于贝叶斯的网状Meta 分析[J].巴楚医学,2021,4(01):69-80.[16]戴永淦,邱德胜,薛小兰等.苯磺酸瑞马唑仑对 ICU 机械通气患者镇静的临床观察[J].医学理论与实践,2023,36(09):1522-1524.[17]Rex D K, Bhandari R, Desta T, et al. A phase III studyevaluating the efficacy and safety of remimazolam (CNS 7056) comparedwith placebo and midazolam in patients undergoing colonoscopy[J].Gastrointestinal endoscopy, 2018, 88(3): 427-437. e6.